Rusnano

Investor type

PE / VC

Founded

2007

AUM

-

Location

Russia

$1-5 m

Investment Ticket

3-5 years

Investment Horizon

Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 06 February, 2026

Profile

RUSNANO was established in March 2011 as an open joint-stock company through reorganization of state corporation Russian Corporation of Nanotechnologies. RUSNANO's mission is to develop the Russian nanotechnology industry through co-investment in nanotechnology projects with substantial economic potential or social benefit. The Government of the Russian Federation owns 100 percent of the shares in RUSNANO. Anatoly Chubais is chairman of the Executive Board of RUSNANO.

Work to establish nanotechnology infrastructure and training for nanotechnology specialists, formerly conducted by the Russian Corporation of Nanotechnologies, has been entrusted to the Fund for Infrastructure and Educational Programs, a non-commercial fund also established through reorganization of the Russian Corporation of Nanotechnologies.

Industry

Biotechnology Healthcare Services

Region of investment

North America Europe

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
7FO3EPcKg9yYdGA8 7FO3EPcKg9yYdGA8
7FO3EPcKg9yYdGA8
avatar
7FO3EPcKg9yYdGA8 7FO3EPcKg9yYdGA8
7FO3EPcKg9yYdGA8
avatar
7FO3EPcKg9yYdGA8 7FO3EPcKg9yYdGA8
7FO3EPcKg9yYdGA8
avatar
7FO3EPcKg9yYdGA8 7FO3EPcKg9yYdGA8
7FO3EPcKg9yYdGA8
avatar
7FO3EPcKg9yYdGA8 7FO3EPcKg9yYdGA8
7FO3EPcKg9yYdGA8
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Rusnano

Rusnano is located in Russia.
Rusnano was founded in 2007.
Rusnano invests in companies and startups in Biotechnology, Healthcare Services.
Rusnano invests in companies and startups in North America, Europe.
Rusnano invests in companies and startups at Series A.
Rusnano usually invests $1-5 m on average.